Deal snapshot: NewAmsterdam Pharma to Merge with SPAC.

MANews-(C)2009-2022

Netherlands-based late clinical-stage company NewAmsterdam Pharma Holding B.V., which is focused on the research and development of transformative oral therapies for major cardiometabolic diseases, and US-based special purpose acquisition company Frazier Lifesciences Ccquisition Corp, which is sponsored by an affiliate of Frazier Healthcare Partners, have entered into a definitive business combination agreement, the companies said.

Upon closing of...

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT